Glaukos Corp. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (128)

Latest Posts

About This Stock More About This Stock
Wells Fargo Downgrades Glaukos To Sell On IStent Reimbursement Cuts
Article By: The Fly
Tuesday, July 20, 2021 9:48 AM EDT
Wells Fargo analyst Lawrence Biegelsen downgraded Glaukos to Underweight from Equal Weight with a price target of $41, down from $100.
In this article: GKOS
Read
Glaukos Plunges After CMS Suggests Slashing Istent Reimbursement
Article By: The Fly
Wednesday, July 14, 2021 11:34 AM EDT
William Blair downgraded Glaukos following the "disappointing and surprising" CMS rate announcement.
In this article: GKOS
Read
Report From J.P.Morgan Healthcare Conference 2021: Current Portfolio Positions #1
Article By: Rod Raynovich
Thursday, January 14, 2021 5:42 AM EDT
The Conference boosted many stocks as you might expect in a bull market for biotech. We reviewed rather quickly some of the presentations from the JPMorgan Healthcare Conference and will comment on specific companies and stocks in a series of posts.
In this article: ABT, BMY, GNMK, IBB, HOLX, PACB, XBI, ABBV, AXDX, GKOS, TDOC, VIR Also: AZN, GSK, MRNA, BNTX, JPM
Read
New Buy Ideas For 2020: Glaukos Corporation (GKOS)
Article By: Rod Raynovich
Thursday, January 30, 2020 2:17 AM EDT
Glaukos new products are rolling out in 2020 so there is revenue and earnings risk because of new technology and competition.
In this article: IHI, GKOS Also: IBB, XBI, XLV
Read
Analyst Defends Glaukos After Reimbursement Cut Recommended
Article By: The Fly
Thursday, April 13, 2017 12:38 PM EDT
After Noridian, a Medicare administrator, proposed drastically lowering the physician reimbursement rate for Glaukos' iStent implant, Wells Fargo sees the reduction as unjustified.
In this article: GKOS
Read

Latest Tweets for $GKOS

No tweets yet!

PARTNER HEADLINES